{"nct_id":"NCT05038735","title":"Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2021-12-17","start_date_type":"ACTUAL","primary_completion_date":"2026-09-15","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-15","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}